As of 05/27/2025, NuCana plc's market capitalization has reached $231,376. According to our data, NuCana plc is the 48655th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap
231,376
Revenue (ttm)
0
Net Income (ttm)
-23,782,816
Shares Out
6.06 M
EPS (ttm)
-8.01
Forward PE
0.00
Ex-Dividend Date
n/a
Earnings Date
06/03/2025
Market Cap Chart
Data Updated: 05/27/2025
NuCana plc's yearly market capitalization.
NuCana plc has seen its market value drop from $227.53 M to $231,376 since 2020, representing a total decrease of 99.90% and an annual compound decline rate (CAGR) of 79.08%.
Date
Market Cap
Change (%)
05/27/2025
$231,376
-95.07%
12/31/2024
$4.67 M
-69.8%
12/29/2023
$15.47 M
-54.66%
12/30/2022
$34.12 M
-72.26%
12/31/2021
$123.00 M
-45.94%
12/31/2020
$227.53 M
Company Profile
NuCana plc was founded in 1997 in United Kingdom.
The company went public on 09/28/2017
on the Nasdaq Stock Market.
With 22 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of 05/27/2025, NuCana plc (including the parent company, if applicable) has an estimated market capitalization of $231,376 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
NuCana plc global market capitalization ranking is approximately 48655 as of 05/27/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.